ATG:biosynthetics GmbH

German synthetic biology company offering PepID peptide construction and expression technology for rational, compact biohost-derived peptide libraries. Services include gene synthesis, DNA optimization (EvoMag), multi-gene/protein expression systems (E. coli, insect cells, mammalian cells), and synthetic biology consulting. Provides an alternative to chemical peptide synthesis via bio-based production.

Directory assessment: ATG:biosynthetics GmbH is listed as a service provider in the peptide supply chain, serving Europe markets from Germany. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.